Pediatric differentiated thyroid carcinoma: trends in practice and outcomes over 40 years at a single tertiary care institution

Olmsted, Courtney L.; Arunachalam, Rajalakshmi; Gao, Xiang; Pesce, Liuska; Lal, Geeta

doi:10.1515/jpem-2016-0327

Cited by 7 publications

(1 citation statement)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Rubinstein et al suggested that an aggressive surgical approach may simultaneously decrease the risk of recurrence and improve prognosis in patients with more advanced or aggressive disease ( 94 ). Olmsted et al showed no difference in recurrence-free survival among patients treated with LND compared to limited node excision of no LND ( 95 ). However, location of LND was not specified.…”

Section: [C] Thyroid Carcinoma Management Guidelinementioning

confidence: 99%

2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma

Lebbink

Links

Czarniecka

et al. 2022

European Thyroid Journal

View full text Add to dashboard Cite

At present no European recommendations for the management of pediatric thyroid nodules and differentiated thyroid carcinoma (DTC) exist. Differences in clinical, molecular, and pathological characteristics between pediatric and adult DTC emphasize the need for specific recommendations for the pediatric population. An expert panel was instituted by the executive committee of the European Thyroid Association (ETA) including an international community of experts from a variety of disciplines including pediatric and adult endocrinology, pathology, endocrine surgery, nuclear medicine, clinical genetics, and oncology. The American Thyroid Association (ATA) pediatric guideline 2015 was used as framework for the present guideline. Areas of discordance were identified, and clinical questions were formulated. The expert panel members discussed the evidence and formulated recommendations based upon the latest evidence and expert opinion. Children with a thyroid nodule or DTC require expert care in an experienced center. The present guideline provides guidance for healthcare professionals to make well-considered decisions together with patients and parents regarding diagnostics, treatment and follow-up of pediatric thyroid nodules and DTC.

show abstract

Section: [C] Thyroid Carcinoma Management Guidelinementioning

confidence: 99%

2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma

Lebbink

Links

Czarniecka

et al. 2022

European Thyroid Journal

View full text Add to dashboard Cite

show abstract

Pulmonary metastases in children and adolescents with papillary thyroid cancer in China: prognostic factors and outcomes from treatment with 131I

et al. 2018

View full text Add to dashboard Cite

show abstract

The Prognostic Power of Preablation Stimulated Thyroglobulin in Children With Differentiated Thyroid Cancer

Nesari Javan,

Askari,

Shafiei

et al. 2024

Endocrine Practice

View full text Add to dashboard Cite

Pediatric differentiated thyroid carcinoma: trends in practice and outcomes over 40 years at a single tertiary care institution

Abstract: Increased use of US and FNA has affected initial surgical management in the latter part of the study, possibly due to extension of adult DTC guidelines. The effects of the new pediatric DTC guidelines need further study.

Cited by 7 publications

References 29 publications

2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma

2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma

Pulmonary metastases in children and adolescents with papillary thyroid cancer in China: prognostic factors and outcomes from treatment with 131I

The Prognostic Power of Preablation Stimulated Thyroglobulin in Children With Differentiated Thyroid Cancer

Contact Info

Product

Resources

About